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Memory precision of object-location binding is
unimpaired in APOE e4-carriers with spatial
navigation deficits
Helena M. Gellersen,1 Gillian Coughlan,2 Michael Hornberger3 and Jon S. Simons1
Research suggests that tests of memory fidelity, feature binding and spatial navigation are promising for early detection of subtle
behavioural changes related to Alzheimer’s disease. In the absence of longitudinal data, one way of testing the early detection po-
tential of cognitive tasks is through the comparison of individuals at different genetic risk for Alzheimer’s dementia. Most studies
have done so using samples aged 70 years or older. Here, we tested whether memory fidelity of long-term object-location binding
may be a sensitive marker even among cognitively healthy individuals in their mid-60s by comparing participants at low and higher
risk based on presence of the e4-allele of the apolipoprotein gene (n¼ 26 e3e3, n¼ 20 e3e4 carriers). We used a continuous report
paradigm in a visual memory task that required participants to recreate the spatial position of objects in a scene. We employed
mixture modelling to estimate the two distinct memory processes that underpin the trial-by-trial variation in localization errors: re-
trieval success which indexes the proportion of trials where participants recalled any information about an object’s position and
the precision with which participants retrieved this information. Prior work has shown that these memory paradigms that separate
retrieval success from precision are capable of detecting subtle differences in mnemonic fidelity even when retrieval success could
not. Nonetheless, Bayesian analyses found good evidence that e3e4 carriers did not remember fewer object locations [F(1, 42) ¼
0.450, P ¼ 0.506, BF01 ¼ 3.02], nor was their precision for the spatial position of objects reduced compared to e3e3 carriers [F(1,
42) ¼ 0.12, P ¼ 0.726, BF01 ¼ 3.19]. Because the participants in the sample presented here were a subset of a study on apolipo-
protein e4-carrier status and spatial navigation in the Sea Hero Quest game [Coughlan et al., 2019. PNAS, 116(9)], we obtained
these data to contrast genetic effects on the two tasks within the same sample (n¼ 33). Despite the smaller sample size, wayfinding
deficits among e3e4 carriers could be replicated [F(1, 33) ¼ 5.60, P ¼ 0.024, BF10 ¼ 3.44]. Object-location memory metrics and
spatial navigation scores were not correlated (all r < 0.25, P > 0.1, 0 < BF10 < 3). These findings show spared object-location
binding in the presence of a detrimental apolipoprotein e4 effect on spatial navigation. This suggests that the sensitivity of memory
fidelity and binding tasks may not extend to individuals with one e4-allele in their early to mid-60s. The results provide further
support to prior proposals that spatial navigation may be a sensitive marker for the earliest cognitive changes in Alzheimer’s dis-
ease, even before episodic memory.
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Abbreviations: APOE ¼ apolipoprotein; BF ¼ Bayes Factor; MCI ¼ mild cognitive impairment; pU ¼ proportion of incorrectly
remembered trials as estimated in the mixture model approach; pT ¼ proportion of correctly remembered trials as estimated in the
mixture model approach; SD ¼ standard deviation; SHQ ¼Sea Hero Quest
Introduction
Alzheimer’s disease has a long preclinical phase during
which pathological neural changes occur without overt,
detrimental effects on behaviour.1–4 This long preclinical
phase offers the possibility of interventions that may tar-
get further pathological changes and prevent irreversible
cell death.5,6 Cognitive tests are the most cost-effective
and simple way to screen for cognitive impairment
related to dementia, yet standard neuropsychological tests
typically fail to detect these subtle preclinical symptoms
of Alzheimer’s disease pathology.7,8 In the absence of lon-
gitudinal data, individuals with high risk for late-onset
Alzheimer’s disease based on the e4-allele of the apolipo-
protein (APOE) gene are a good model to test the diag-
nostic sensitivity of cognitive tests because they are more
likely than e3e3 carriers to develop the disease, exhibit
Alzheimer’s disease pathology at an earlier point in time
and decline at a more rapid rate.9–15 E4-carriers exhibit
deficits in tests of long-term feature binding, mnemonic
fidelity and spatial navigation, making these tasks prom-
ising markers of incipient cognitive decline related to
Alzheimer’s disease.16–18 Yet, there are few studies testing
these tasks in neuropsychologically unimpaired middle-
aged e4-carriers, and even fewer studies looked at more
than one of these different types of tasks in the same
sample. Here, we determined whether a novel test of
long-term object-location binding is sensitive to APOE
effects in a sample with e3e4 carriers who previously
exhibited spatial navigation deficits.19
Older adults, individuals with mild cognitive impair-
ment (MCI) and preclinical individuals with positive
Alzheimer’s disease biomarkers are impaired on mnemon-
ic discrimination of novel and studied targets under con-
ditions of high feature overlap.20–31 Similarly, cognitively
healthy preclinical adults (defined by APOE genotype or
Alzheimer’s disease pathologies), as well as MCI and
Alzheimer’s disease patients, also perform significantly
worse in tests of feature binding, showing a marked de-
cline in representational fidelity.18,32–52
We capitalize on current evidence for subtle cognitive
deficits in preclinical Alzheimer’s disease by using a mem-
ory precision task with demands on memory binding and
fidelity of mnemonic representations, abilities that are
particularly affected by Alzheimer’s disease pathology
even from preclinical stages onwards.6,29,53 We use study-
test delays that preclude the use of short-term memory.
E4-carriers have an advantage in short study-test delays
but may be predisposed to accelerated rate of forgetting
thereafter.18,52 A longer study-test delay may be able to
index such faster forgetting. We hypothesized that our
task design may detect e4-dependent differences because
(i) the task involves entorhinal and hippocampal medi-
ated relational binding of objects and locations, which is
impaired in prodromal Alzheimer’s disease28,54–57; (ii) a
continuous metric may be a more sensitive index than
categorical measures of retrieval51,58; and (iii) memory fi-
delity relies on communication between hippocampus and
cortical regions, which exhibit altered connectivity in the
early course of Alzheimer’s disease.1,59–68
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Only one study has tested the fidelity of relational
binding with longer memory retention intervals using
continuous report paradigms in an APOE genotyped co-
hort in their 60s,18 showing a reduction in the fidelity of
object-location binding for older preclinical e4 homozy-
gotes. No such effect was present in e3e4 heterozygotes
when using the mean error between target location and
response as a performance metric. The presence of an ef-
fect of the e4-allele on the fidelity of long-term object-
memory binding is promising as it suggests that this task
is potentially sensitive to preclinical Alzheimer’s disease-
related changes even in individuals in their 60s.
Performance reductions might be observed not just in e4
homozygotes but also heterozygotes for object-location
binding when using a more sensitive index than mean lo-
calization error, such as localization precision which con-
trols for accessibility of any information from memory.
Another option may be to increase interference by adding
more objects to studied scenes to place further demands
on transentorhinal and hippocampal processes,69–71 there-
by resulting in more misbinding errors among individuals
with poorer mnemonic representations.41,57 Here, we use
both approaches to investigate whether continuous report
paradigms can be made even more sensitive to
Alzheimer’s disease risk.
We examine the utility of this novel test of memory fi-
delity of relational binding that engages regions vulner-
able to early Alzheimer’s disease, supplemented with a
mixture modelling approach that specifically indexes pre-
cision, to test the effect of the e4-allele on the precision
of object-location binding beyond short-term memory re-
tention. We compare model-derived metrics with those
used in prior studies with continuous report paradigms
such as those by Zokaei et al. (2019) to determine if the
separation of precision and retrieval success may be able
to tease apart subtle APOE effects on memory abilities.19
We apply our test to a sample that has previously been
characterized in terms of spatial navigation abilities.19 An
added benefit of our study is therefore to test whether a
fidelity metric for spatial memory will be similarly sensi-
tive to Alzheimer’s disease risk as spatial navigation
measures. To our knowledge, no other study to date pro-
vides data on the effect of the e4-allele on spatial mem-




The study was carried out at the University of East
Anglia, Norwich with ethical approval from the Faculty
of Medicine and Health Sciences Ethics Committee at
UEA (Reference FMH/2016/2017–11). Exclusion criteria
were cognitive impairment and neuropychiatric condi-
tions. Participants provided written informed consent
before participation. The sample presented here was pre-
viously described by Coughlan and colleagues (2019).19
The sample size was based on that of prior studies that
investigated the effect of the e4-allele on spatial
navigation.72
Forty-nine participants completed the spatial precision
memory task. We included n¼ 26 individuals with the
e3e3 genotype aged 53 to 74 (M¼ 63.38, SD¼ 6.07; 13
females) and n¼ 20 individuals with the e3e4 genotype
aged 54 to 80 (M¼ 64.80, SD¼ 6.83; 5 females) for our
main analysis. Three volunteers with the e4e4 genotype
aged 63 or 64 years also completed the test battery
(M¼ 63.33, SD¼0.58; 1 female). Given the small number
of e4 homozygotes and the differences between e3e4 and
e4e4 carriers in general, our main analysis focused on a
comparison of e3e3 carriers and e3e4 heterozygotes to
avoid the admixture of different genotypes. In a sensitiv-
ity analysis, we determined whether the addition of the
high risk e4 homozygotes influenced the results. Sample
demographics and standard neuropsychological scores are
shown in Table 1.
In this sample, Coughlan and colleagues previously
tested spatial navigation performance at two time
points.19,73 Sixty participants (n¼29 e3e3, n¼31 e3e4)
completed the Sea Hero Quest (SHQ) at baseline. At fol-
low-up, 59 remained to complete the spatial navigation
tasks, 49 of whom were also given the precision memory
task and are included in this study. We then compared
the spatial navigation data from the baseline assessment
with our object-location precision memory task from the
follow-up session. Although this has the caveat that the
spatial navigation data were obtained 18 months prior to
the memory data, we decided that the issue of practise
effects at re-test was a greater confound because it could
have allowed participants to develop strategies to better
cope with the demands of the spatial navigation task. In
Table 1 Demographics and standard neuropsychologic-










Age 63.4 (6.07) 64.8 (6.83) 63.3 (0.58)
Sex
Female 13 (50%) 5 (25%) 1 (33%)
2 (67%)
Male 13 (50%) 15 (75%)
Education 14.25 (2.31) 13.80 (2.26) 14.67 (0.58)
ACE Total 93.9 (4.91) 94.6 (2.42) 93.0 (3.61)
ACE Memory 25.0 (1.50) 25.1 (1.00) 24.7 (1.53)
ROCF immediate 33.3 (2.59) 31.8 (2.69) 32.0 (2.65)
ROCF delayed 21.4 (5.73) 21.9 (4.67) 22.2 (9.78)
ACE, Addenbrookes Cognitive Examination; ROCF, Rey-Osterrieth Complex Figure.
Delayed copy was three minutes after presentation. The genotype groups did not
differ significantly in terms of age [F(2,46) ¼ 0.30, P ¼ 0.739] or scores on the
Addenbrookes Cognitive Examination (ACE) regardless of whether the total score
[F(2,46) ¼ 0.11, P ¼ 0.90] or the memory sub-score was used [F(2,46) ¼ 0.28, P ¼
0.760].
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their test–retest analysis, Coughlan et al. (2020) suggest
that this may have indeed been the case and that the re-
duction of novelty in the spatial navigation task may re-
duce its diagnostic utility because poor performers
improved more than those with initially better scores.
Using the first assessment of both memory and spatial
navigation tasks is therefore more informative to deter-
mine whether effects of APOE can be observed in each
cognitive function.
Precision memory task
Details of the precision memory task can be found in the
Supplementary Material.
Briefly, participants were asked to remember the iden-
tity and locations of objects in a scene. Each encoding
display consisted of a trial-unique background image
with three objects pseudorandomly arranged around an
invisible circle centred at the midpoint of the image
(Fig. 1). Object positions were constrained to maintain a
minimum of 62.04 between objects to avoid spatial
overlap. Participants undertook five practice trials before
beginning the actual task. The main task comprised five
study-test blocks. In each of the five blocks, participants
first viewed five displays during the study phase. After
encoding, an interference task required participants to
count backwards from a random number between 50
and 100 for 12 s to prevent active rehearsal of memo-
rized displays. Each test trial began with an identification
question where participants were asked to determine
which of two presented objects had previously been
shown. If they chose correctly, the associated background
image appeared, and participants were asked to move the
object around the screen to recreate its studied location
as precisely as possible. Participants viewed 25 displays
and completed 75 test trials, each containing an identifi-
cation and a localization question.
Spatial navigation task
To compare the effects of APOE on the object-location
memory task and spatial navigation in this same sample,
we obtained the previously published spatial navigation
data,19,73 from the Sea Hero Quest app.74 The SHQ has
previously been described in detail. Briefly, SHQ is a
game in which participants navigate through a virtual en-
vironment to reach checkpoints described on a map they
study at the beginning of each level. Crucially, the maps
are shown in an allocentric perspective but once a level
begins, participants navigate based on an egocentric
Figure 1 Schematic of the precision memory task.
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viewpoint. Participants played three different levels.
Performance metrics were wayfinding distance and aver-
age distance to the border of an environment to index
border bias.19
APOE genotyping
DNA samples were obtained with a Darcon tip buccal
swab (LE11 5RG; Fisher Scientific). Swabs were refriger-
ated at 2–4C before DNA was extracted using the
QIAGEN QIAamp DNA Mini Kit (M15 6SH; QIAGEN).
DNA was quantified by analysing 2-ll aliquots of each
extraction on a QUBIT 3.0 fluorometer (LE11 5RG;
Fisher Scientific). DNA extractions were confirmed by the
presence of a DNA concentration of 1.5 lg or higher per
100 lg of AE buffer as indicated on the QUBIT reading.
PCR amplification and plate read analysis was performed
using Applied Biosystems 7500 Fast Real-Time PCR
System (TN23 4FD; Thermo Fisher Scientific). TaqMan
Genotyping Master Mix was mixed with two single-nu-
cleotide polymorphisms of the apolipoprotein (rs429358
at codon 112 and rs7412 at codon 158). These two sin-
gle-nucleotide polymorphisms determine the genotypes as




Models fitted to the data and distribution of responses
across all participants by genotype are shown in Fig. 2.
We fit probabilistic mixture models to the location place-
ment errors expressed as the degrees separating the re-
sponse from the target.67,75–78 The approach aims to
determine the distribution of trial responses in order to
examine which retrieval mechanisms best explain the
observed responses: (i) correctly recalled locations; (ii)
random guesses; or (iii) a misbinding error in which the
location of the target is confused with that of another
object from the same display. Guess trials were modelled
using a uniform distribution. The proportion of trials
within the uniform distribution represents the guess rate
pU and 1-pU expresses retrieval success pT. Correctly
remembered items were modelled by a circular Gaussian
(von Mises) distribution centred at the target location
with its standard deviation (SD) reflecting the precision
with which locations are recalled. Larger SDs correspond
to lower localization fidelity. Misbinding errors were
modelled by von Mises distributions centred around the
two distractor items.
To maximize comparability with the only other study
on the effect of the APOE genotype on location memory
precision,77 we also used Bayesian modelling implemented
with the MemToolbox in MATLAB 2016a.75 We fit
three models to the error data collapsed across all partici-
pants by APOE genotype group to test which compo-
nents could explain localization performance. The models
contained the following components (Fig. 2A): Model 1
(von Mises distribution) assumes that no guessing
occurred; Model 2 (uniform þ von Mises distribution)
assumes that responses reflect a mixture of guessed trials
and correctly recalled locations with response-to-target
distance varying across trials; Model 3 (uniform þ von
Mises þ von Mises for non-targets) extends Model 2 by
assuming that some incorrect responses were due to ob-
ject-location misbinding. Deviance Information Criterion
favoured Model 2. All further analyses are conducted
using this model. For more details on modelling and
comparison with an alternative model fitting procedure
based on work by Bays and colleagues51,67 refer to the
Supplementary Material.
This approach allowed us to test if the e4-allele affects
the probability of correctly retrieving information from
memory and/or mnemonic fidelity (i.e. precision with
which this information is recalled). Mixture modelling is
superior to other approaches that distinguish between re-
trieval success and fidelity of retrieved information be-
cause the estimation of the uniform distribution accounts
for guess responses placed near the target item.
We calculated retrieval success and precision for each
subject. To improve robustness of estimates for precision
and retrieval success, we calculated a cut-off for guessing
from the mixture modelling approach across the full sam-
ple following the examples of prior studies (for details
see Supplementary Material).51,67 Localization errors
exceeding 63 response-to-target distance were deemed as
failure to retrieve an object’s location. For each subject,
we calculated retrieval success as the proportion of trials
with errors 63. A measure of imprecision was derived
from the SD across all responses with localization errors
63.
APOE group differences memory performance
We employed a combination of frequentist (two-tailed
tests with a statistical significance level of P < 0.05) and
Bayesian methods to test for APOE genotype effects.
Mixture modelling by APOE genotype group. We first
tested for differences in guessing (pU) and imprecision
(SD) estimates for the standard mixture models fit to all
responses across subjects in the e3e3-carrier and e3e4-car-
rier group, respectively. To obtain a P-value, true group
differences were compared to the distribution of standar-
dized differences obtained from random group assign-
ments over 1000 permutations (sample 1 with n¼ 26 to
match the number of participants in the e3e3 group;
sample 2 with n¼ 20, as in the e3e4 group). This ap-
proach has the advantage of operating on more robust
model parameters due to reduced noise resulting from
larger number of trials available for mixture modelling.
APOE effects based on single-subject scores. Next, we
carried out analyses on individual subject data while con-
trolling for nuisance variables using a linear model with
sex and age as covariates and APOE genotype as be-
tween-subjects factor of interest. Dependent variables
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Figure 2 Tested models and results from the mixture modelling approach. (A) Proposed models to capture location memory
performance. In Model 1, all object locations are assumed to be correctly recalled without any guess responses (probability of guessing: pU¼0).
The mean distance of responses from the target can be represented by the width of the von Mises (circular Gaussian) distribution, expressing
the precision of memory recall [expressed as the standard deviation (SD) of the von Mises distribution where higher values reflect lower
precision; for a more intuitive interpretation where higher values reflect better performance, the SD value can be converted to the von Mises
distribution concentration parameter kappa, denoted K; see Supplementary Material]. Model 2 assumes a mixture of guessed and correctly
remembered responses, where the proportion of responses that fall within the uniform distribution is denoted by the parameter pU that
captures the proportion of guessed responses. For a more intuitive understanding where higher values reflect higher performance this
parameter can also be expressed as retrieval success denoted by pT. This parameter captures the proportion of trials within the von Mises
distribution, i.e. trials in which the target location was correctly recalled. Model 3 assumes that responses reflect a combination of guessing,
correctly remembered responses with variable degree of precision, and swaps of target and distractor locations, represented as von Mises
distributions centered at the locations of distractor objects. (B) Distribution of location errors by e4-status in native circular space (left hand
side) and the Standard Mixture Model (von Mises þ uniform) fit to responses. Model 2 was identified as the best fitting model in a model
comparison procedure detailed in the Supplementary Material.
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were the proportion of correctly identified items, and the
measures of retrieval success and precision. Cohen’s f2
was used to denote the effect size of the R2-change from
a model with covariates (age, sex) to a model with
APOE genotype (e3e3 versus e3e4). We also calculated
the Bayes Factor (BF) for the contrast of the model with
covariates and the full model with covariates and APOE
genotype as between-subjects factor of interest using the
R package BayesFactor (https://CRAN.R-project.org/pack
age¼BayesFactor; last accessed May 2021). A BF of >3
was deemed as good evidence in support of the alterna-
tive hypothesis if indexed by B10 and for the null hypoth-
esis if indexed by B01.
51,79,80
Supplementary analyses for precision memory. In order to
make our results more comparable with prior studies that
used a similar object-location binding paradigm without
mixture modelling to separate retrieval success from preci-
sion,18,81 we also calculated the mean absolute error be-
tween targets and responses to determine whether a
modelling approach to separate retrieval success and mem-
ory precision may be more sensitive to detect APOE effects.
We conducted a control analysis termed ‘nearest neigh-
bour analysis’ as used in prior work.18,82 This analysis
allowed us to test whether there was a difference in the
nature of incorrect responses between genetic groups by
considering the occurrence of misbinding errors. A signifi-
cant APOE effect on the distance to the nearest neigh-
bour would suggest that error responses in the two
groups are not caused by the same mechanisms. The
group with significantly smaller nearest neighbour differ-
ence is likely to commit more misbinding errors.
Prior work has demonstrated an interaction between
study-test delay and the e4-allele on short-term memory
versions of continuous object-location tests with e4-car-
riers at an advantage at short delays of 1 s which sub-
sides at longer delays beyond 4 s.77,81 Using the
correlation between localization error and study-test delay
in each subject, we tested whether e4-carriers exhibit
steeper performance decline as a function of delay.
Finally, we carried out robustness analyses to determine
whether inclusion of high-risk homozygous e4e4 carriers
affected our results using the same models described
above. In these analyses the between-subjects factor was
e4-allele carrier status (none versus any).
APOE group differences in spatial navigation perform-
ance and its relationship to object-location memory. We
tested whether the APOE effect previously observed in the
full sample of n¼ 60 participants persisted in this smaller
subset of participants who also completed the memory task
(n¼ 33). We did so by running general linear models with
genotype, sex and age on the spatial navigation outcome
measures. Dependent variables were mean wayfinding dis-
tance and border bias in the SHQ game.19 We also tested
for an association between spatial navigation and object-lo-
cation memory by running Pearson correlations, supple-
mented with Bayesian analyses.
Data availability
Summary data for precision memory metrics and spatial
navigation are available through the Open Science
Framework (memory: https://osf.io/42sp9/; spatial naviga-
tion: https://osf.io/6adqk/; all last accessed in May 2021).
The code for Bayesian mixture modelling with the
MemToolbox can be obtained through http://visionlab.
github.io/MemToolbox/.75 Code for mixture modelling
using a maximum likelihood estimation implemented by
Paul Bays and colleagues is available at https://www.bay
slab.com/toolbox/index.php.78
Results
A summary of the memory performance metrics as a
function of APOE group is shown in Table 2. Fig. 3
shows memory and spatial navigation performance by
genotype.
Group differences based on memory metrics derived
from modelling across subjects by APOE group. The
results of the permutation analysis are shown in Fig. 3A.
The error distributions across subjects in each APOE
group exhibited considerable overlap. The distribution of
permutation-based group differences derived from random
Table 2 Summary of memory performance across subjects by APOE genotype
Metric e3e3 (n 5 26) e3e4 (n 5 23) All e4 carriers (n 5 26)
Identification accuracy (% correct) 0.83 (0.06) 0.82 (0.08) 0.83 (0.08)
Location retrieval success (% correct) 0.80 (0.13) 0.80 (0.16) 0.81 (0.15)
Localization Precision (standard deviation in degrees) 22.4 (5.31) 22.1 (3.97) 22.16 (4.09)
Mean target-response distance (mean degrees) 36.5 (16.1) 35.1 (16.2) 34.10 (15.7)
Mean distance to nearest item (mean degrees) 20.7 (5.60) 21.0 (5.00) 20.67 (4.84)
Model-derived estimates calculated across all subjects per group
pU [95% CI] 0.31 [0.28; 0.34] 0.29 [0.26; 0.33] 0.30 [0.28; 0.33]
SD [95% CI] 17.90 [16.82; 19.32] 18.84 [17.54; 20.49] 18.35 [17.43; 19.30]
The upper rows show performance metrics that were first calculated separately for each individual and then averaged across all participants in each genotype group. Single-subject
estimates of retrieval success and precision were calculated based on a model derived cut-off score for guessing at a response-to-target distance of 63 (see Supplementary material
for details). The bottom two rows show the mixture model parameter estimates derived from fitting Model 2 to all error responses from participants in one group (e.g. e3e4). CI:
credibility interval of the posterior distribution derived from the Bayesian estimation procedure; pU: proportion of guessing where lower values indicate better performance; SD:
precision where lower values indicate better performance.
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assignments to groups confirmed that guessing and im-
precision were equivalent in the two APOE groups
(guessing: z ¼0.31, P ¼ 0.704; imprecision: z ¼ 0.59,
P ¼ 0.555).
Group differences based on single-subject memory met-
rics. The linear models controlling for age and sex found
no significant effect of APOE on identification of objects
[F(1, 42) ¼ 1.14, P ¼ 0.292, f2 ¼ 0.03, BF01 ¼ 2.17],
retrieval success for object locations [F(1, 42) ¼ 0.45, P
¼ 0.506, f2 ¼ 0.01, BF01 ¼ 3.02], the precision of recre-
ating locations of correctly retrieved items [F(1, 42) ¼
0.12, P ¼ 0.726, f2 < 0.01, BF01 ¼ 3.19], or the mean
absolute angular disparity between targets and responses
across all trials [F(1, 42) ¼ 0.12, P ¼ 0.729, f2 < 0.01,
BF01 ¼ 3.37].
Misbinding errors and study-test delay. E4-carriers did
not commit more misbinding errors [F(1, 42) ¼ 0.83,
P ¼ 0.367, f2 ¼ 0.02, BF01 ¼ 2.54] or exhibited acceler-
ated forgetting as a function of study-test delay [F(1, 42)
¼ 0.02, P ¼ 0.890, f2 < 0.01, BF01 ¼ 3.37]. All null
results held even after inclusion of e4 homozygotes
(Supplementary Material).
Effects of APOE e4 on spatial
navigation
In line with the findings from the full sample in
Coughlan and colleagues (2019), among participants who
completed both the memory precision and the SHQ task
e3e4 carriers had a longer mean wayfinding distance
Figure 3 Precision memory and spatial navigation performance by APOE genotype. (A) Distribution of standardized group
differences derived from 1000 permutations where n ¼ 26 subjects were randomly assigned to one sample and n ¼ 20 subjects to another
(to match the actual group sizes in our sample). Retrieval success and precision were obtained using mixture modelling on all trials across
subjects for the e3e3 and the e3e4 group, respectively. The red dots represent the standardized true differences in model metrics calculated
by subtracting the scores of the e3e4 from those of the e3e3 group (for guessing, pU: z ¼ 0.31; for precision, SD: z ¼ 0.5). (B) Mean 6
standard deviation of identification accuracy, retrieval success and precision for each APOE group. Retrieval success refers to the proportion
of trials falling within 63 of the target object. Precision reflects the standard deviation in response-to-target distance for all trials within 63
of the target object. The APOE effect on memory scores and spatial navigation is assessed using general linear models and Bayesian analysis.
(C) Mean 6 standard deviation of wayfinding distance in the Sea Hero Quest game (Coughlan et al., 2019). *P < 0.05
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than e3e3 carriers [F(1, 33) ¼ 5.60, P ¼ 0.024, f2 ¼
0.17, BF10 ¼ 3.44]. E3e4 carriers in our sub-sample also
showed a significant border bias, although the BF did
not quite reach the required cut-off of 3 [F(1, 33) ¼
4.54, P ¼ 0.041, f2 ¼ 0.14, BF10 ¼ 2.55], as it did in
the original larger sample (BF10 ¼ 4.22).
Neither wayfinding distance, nor border bias signifi-
cantly correlated with retrieval success, precision, mean
absolute localization error, or swap errors (all r < 0.25,
P > 0.1). However, the Bayesian analysis could not es-
tablish clear support for the null hypothesis for the ab-
sence of associations between the object-location memory
and spatial navigation performance metrics (all 0 < BF10
< 3).
Discussion
In this study, we tested whether the precision of long-
term memory for object-location binding is affected in
healthy middle- and older-aged apolipoprotein e4-carriers
who do not exhibit impairments on standard neuro-
psychological tests. We used a continuous report para-
digm in which participants were asked to recreate object
locations as precisely as possible67 and employed
Bayesian mixture modelling to separate memory retrieval
success from the precision of retrieved locations.75,78 We
hypothesized that the precision task combined with mix-
ture modelling may be capable of identifying subtle
changes in memory fidelity in preclinical e4-carriers.
Previously, preclinical e4 homozygotes at high risk of
Alzheimer’s disease were impaired on a similar long-term
memory fidelity task, while heterozygotes were not.18
Here, we aimed to increase sensitivity of such continuous
report paradigms by increasing the to-be-recalled informa-
tion per test display and by separating memory precision
from retrieval success. We then tested if these adjustments
may be capable of picking up subtle differences between
controls and a genetic risk group, even if the risk group
was comprised of individuals with moderate genetic risk
of Alzheimer’s disease (e4 heterozygotes), around half of
whom are expected to develop the disease.12
However, we found robust evidence for the absence of
an effect of the e4-allele on object-location long-term
memory performance in middle-aged and older adults, re-
gardless of whether the risk groups included only e4 het-
erozygotes or additionally added the e4 high-risk
homozygotes. Carriers of the e4-allele did not recall fewer
locations of objects, nor was the precision of their
retrieved object-location associations affected. E4-carriers
also did not commit more misbinding errors of item iden-
tity and location. There was no evidence for accelerated
forgetting in e4-carriers as opposed to non-carriers. To
our knowledge, this is the first study comparing cogni-
tively healthy APOE genotype groups, while using a mix-
ture modelling approach to separate retrieval success
from retrieval precision in a task with study-test delays
that prevented the involvement of short-term memory.
Intriguingly, despite this absence of spatial memory defi-
cits, the e4-carriers in this sample did exhibit altered
wayfinding trajectories in real-time while navigating a
virtual environment in the SHQ game.19 Moreover, per-
formance on object-location memory and spatial naviga-
tion was unrelated.
Few studies have previously investigated memory fidel-
ity in individuals at higher risk for Alzheimer’s disease
during preclinical stages of the disease. Preclinical individ-
uals with higher Alzheimer’s disease risk based on bio-
markers or the APOE genotype have been reported to
show poorer performance in mnemonic discrimination
(combined group of heterozygotes and homozygotes) and
continuous report tasks of feature binding in long-term
memory (homozygotes).29,41,83 Specifically, they exhibit a
greater tendency to falsely label as old novel lures that
are similar to studied stimuli.29,83,84 They also have
higher rates of misbinding, larger object localization
errors18 and exhibit accelerated forgetting.18,52
These prior findings suggest that both, aspects of mne-
monic discrimination and precision of relational binding
may be sensitive to early Alzheimer’s disease. However,
comparisons between these two tasks in terms of their
relative sensitivity to Alzheimer’s disease risk cannot be
made at this point given the differences in samples of
studies with these tasks in terms of age, neuropsycho-
logical deficits, proportion of e4 heterozygotes and homo-
zygotes and presence of Alzheimer’s disease
pathology.18,29,41,83–86 Based on one prior study, per-
formance on these two tasks is related and may involve
similar but also somewhat dissociable mechanisms.87
Future studies should aim to compare the sensitivity of
mnemonic discrimination tasks and relational binding
tasks for the early detection of Alzheimer’s disease in the
same sample.
Based on prior findings of memory fidelity metrics as
potentially sensitive markers of preclinical Alzheimer’s
disease, it may be surprising that we did not find an
APOE effect on memory. However, previous studies have
included individuals at higher genetic risk due to presence
of the e4e4 genotype or familial Alzheimer’s disease
markers18,41 or included samples that were on average
5 years older than ours (mean ages of 70 versus 65 years)
and which included neuropsychologically impaired indi-
viduals.83,84 Our findings, therefore, suggest that the def-
icit in object-location memory previously identified could
not be detected in individuals that were younger and in a
lower genetic risk category, even when using high-sensi-
tivity metrics derived from mixture modelling.
Consequently, our results do not stand in contrast to
prior findings but rather provide information on the po-
tential diagnostic reach of these tasks.
An alternative strategy to test the sensitivity of early
detection tasks is to classify cognitively normal preclinical
older adults based on tau and amyloid Alzheimer’s dis-
ease biomarker status. To date, this has been done to test
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for the sensitivity of mnemonic discrimination tests,
which show a correlation between both tau and amyloid
beta loads with mnemonic discrimination perform-
ance.26,29,86,88 Mean ages in these samples (70þ) tend to
be significantly older than the participants in the present
study (65), although in one study the association be-
tween tau levels and object mnemonic discrimination
could still be observed in individuals aged below
70 years.29 Interestingly, the association of Alzheimer’s
disease biomarker concentration and mnemonic discrimin-
ation deficits remained even after accounting for APOE
status.26 Findings from these studies suggest that risk
classification based on biomarkers, as opposed to e4-
genotype, may be a better strategy to test the sensitivity
of memory precision for early detection of Alzheimer’s
disease in preclinical samples aged 70 or younger without
cognitive signs on standard tests.89
Despite the absence of a precision memory deficit in
the present sample, Coughlan and colleagues (2019)19
described suboptimal navigation patterns in these same
e3e4 carriers 18-months prior to the test session involving
the precision memory task. Here, we could reproduce the
same wayfinding deficit in the subsample of participants
who completed both the precision memory and the spa-
tial navigation task. This subtle navigational deficit was
attributed to a bias toward navigating close to environ-
mental boundaries, as previously documented in an inde-
pendent cohort.72 This very specific impairment may be a
result of early tau pathology in the entorhinal cortex
thought to alter the integrity of grid cell representations,
which are essential for updating self-motion during navi-
gation.19,72,90–92 This interpretation is in line with recent
evidence suggesting that preclinical e4-carriers only ex-
hibit spatial navigation deficits in the absence of nearby
landmarks or environmental boundaries that normally
correct for accumulating temporal error in the grid cell
code.91,93
Although grid cells are most famously involved in spa-
tial navigation, they also support visual memory.94
Research suggests that both visual and navigational proc-
esses are supported by the entorhinal cortex via common
mechanisms that include the formation of spatial or vis-
ual maps via grid cells.95,96 Specifically, grid cells code
for spatial locations in a visual scene much in the same
way in which they code for space during exploration of
a 3D environment.94,95 Based on these findings, it has
been proposed that grid cells support both spatial naviga-
tion and relational memory.96 It may therefore be surpris-
ing that we did not find any effect in our spatial memory
precision task and that object-location memory was unre-
lated to spatial navigation deficits. However, the border
bias is a very specific behaviour in e4-carriers that
appears when arenas have larger open spaces where
anchoring spatial maps to nearby landmarks cannot be
used as a corrective strategy.19,72,91 Therefore, it has no
direct equivalent in 2D visual scene memory in our preci-
sion task. This may explain why there is an effect of the
e4-allele on virtual reality spatial navigation but not in
object-location memory precision in our sample. A prefer-
ence for environmental borders may indeed be the very
first sign of Alzheimer’s disease risk dependent behaviour-
al changes, whereas impairment in relational memory
may arise at a later stage.83,84,97
Despite our relatively small sample size, our power
analysis suggested that our study had moderate power to
detect an APOE effect on precision memory similar in
magnitude to that that in Coughlan et al. (2019)
(Supplementary Material). Even though power was mod-
erate, we could replicate the navigation deficit in this
smaller subsample and our Bayesian analysis provided
good evidence in favour of a null effect for memory, sug-
gesting that the absence of a genotype effect was not sim-
ply due to an inadequate sample size. If a genotype effect
on object-location precision does indeed exist in this sam-
ple, it is likely to be rather small and may be less mean-
ingful for early detection efforts. This small effect may in
part be due to the high heterogeneity of e3e4 carriers,
given that only a subgroup will move on to actually de-
velop Alzheimer’s disease.11 However, the fact that spa-
tial navigations deficits can still be detected even with a
small sample as seen here and elsewhere,19,72,91 suggests
that it is indeed possible to find genotype effects on cog-
nition with a sensitive task, even though only 47% of
e3e4 carriers will move on to develop Alzheimer’s dis-
ease. Our key conclusion, namely that there is no clear
object-location memory deficit in e3e4 carriers at this age
and therefore tests of relational memory may only detect
e4-dependent deficits at a later point along the
Alzheimer’s disease continuum can still be supported.
To test whether this is indeed the case, it would be in-
formative to follow up the present sample longitudinally to
compare participants who do or do not subsequently ex-
hibit cognitive decline associated with Alzheimer’s disease.
Additionally, as discussed above, a promising strategy to
test the sensitivity of the precision task in preclinical cases
in future studies may be to use biomarkers for classifying
individuals into risk groups. This would not only allow
studies to determine the sensitivity of memory fidelity met-
rics but to also assess the specificity of these tasks to
Alzheimer’s disease-related cognitive decline. This is particu-
larly important given the high heterogeneity of e4-carriers
and MCI patients. To date, there is still a lack of studies
on memory fidelity that stratify MCI patient groups based
on Alzheimer’s disease biomarkers.33,46,47,98
Finally, we argue that it is unlikely that the null find-
ings for object-location memory can be explained on the
basis of antagonistic pleiotropy where middle-aged e4-car-
riers still have an advantage over e3e3 carriers or could
stave off the presence of early Alzheimer’s disease path-
ology. This explanation is supported for short-term ob-
ject-location memory.77,81,98 However, it may be less
applicable in the case of our results in a task that is
more reliant on long-term memory processes and the
medial temporal lobe.97,99–103 Large-scale studies and
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meta-analyses across the lifespan have called into ques-
tion the antagonistic pleiotropy hypothesis in the case of
long-term memory.7,104–106 There is only little support
for an e4-dependent advantage in young age107 but none
for midlife,108 and by older age (comparable to the age
in our sample), homozygotes exhibit greater localization
errors than e3e3 carriers.18 These prior studies suggest
that any potential positive effects of the e4-allele on spa-
tial memory tasks similar to our object-location paradigm
in young adulthood may not carry into late midlife. The
effects of the e4-genotype on long- and short-term mem-
ory may unfold differently across the lifespan and we de-
liberately designed our task to tap into long-term
retention processes for which the prodromal hypothesis
of APOE-e4 is a more likely explanation.
To our knowledge, this is the first study to employ a
modelling approach to separate episodic memory retrieval
success and precision and test the sensitivity of mnemonic
fidelity metrics to preclinical Alzheimer’s disease risk as
measured in a contrast of e3e3 and e3e4 carriers. Prior
work in high-risk Alzheimer’s disease individuals (famil-
ial, e3e4/e4e4, tau and amyloid positive cases) has sug-
gested that object-location memory fidelity may be a
sensitive marker for preclinical Alzheimer’s disease cases
and that this effect can be detected in samples aged 70
and older.18,26,41,83,84 We provide robust evidence that
this may not be the case for e3e4 carriers who were, on
average, five years younger than individuals in prior stud-
ies. The sensitivity of memory fidelity tasks may therefore
not extend to e4 heterozygotes in their early to mid-60s.
Despite no APOE genotype effect on object-location
memory precision, e3e4 carriers in the same sample did
exhibit subtle behavioural deficits in spatial navigation.
These results provide further support to prior proposals
that spatial navigation may be a sensitive marker for the
earliest Alzheimer’s disease-dependent cognitive changes,
even before episodic memory.16,72 More research in pre-
clinical Alzheimer’s disease is needed to confirm this hy-
pothesis by direct comparisons of memory fidelity and
spatial navigation tasks.
Supplementary material
Supplementary material is available at Brain
Communications online.
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32. Parra MA, Saarimäki H, Bastin ME, et al. Memory binding and
white matter integrity in familial Alzheimer’s disease. Brain.
2015;138(Pt 5):1355–1369.
33. Mowrey WB, Lipton RB, Katz MJ, et al. Memory binding test
predicts incident amnestic mild cognitive impairment. J
Alzheimers Dis. 2016;53(4):1585–1595.
34. Chen P-C, Chang Y-L. Associative memory and underlying brain
correlates in older adults with mild cognitive impairment.
Neuropsychologia. 2016;85:216–225.
35. Polcher A, Frommann I, Koppara A, Wolfsgruber S, Jessen F,
Wagner M. Face-name associative recognition deficits in subject-
ive cognitive decline and mild cognitive impairment. J Alzheimers
Dis. 2017;56(3):1185–1196.
36. Delhaye E, Bahri MA, Salmon E, Bastin C. Impaired perceptual
integration and memory for unitized representations are associ-
ated with perirhinal cortex atrophy in Alzheimer’s disease.
Neurobiol Aging. 2019;73:135–144.
37. Oedekoven CSH, Jansen A, Keidel JL, Kircher T, Leube D. The
influence of age and mild cognitive impairment on associative
memory performance and underlying brain networks. Brain
Imaging Behav. 2015;9(4):776–789.
38. Van Geldorp B, Heringa SM, Van Den Berg E, Olde Rikkert
MGM, Biessels GJ, Kessels RPC. Working memory binding and
episodic memory formation in aging, mild cognitive impairment,
and Alzheimers dementia. J Clin Exp Neuropsychol. 2015;37(5):
538–548.
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